Tcr2 Therapeutics Inc (TCRR) Insider Trading
- $13,577,112.71
- $12,456,074.63
- May 25, 2023
- Morana Jovan-Embiricos
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| May 25, 2023 | Major Shareholder | 50,000 | $1.72 | Buy | $86,000.00 | |
| May 22, 2023 | Major Shareholder | 70,170 | $1.88 | Sell | $131,919.60 | |
| May 12, 2023 | Major Shareholder | 6,183 | $1.95 | Buy | $12,056.85 | |
| May 10, 2023 | Major Shareholder | 6,774 | $1.95 | Buy | $13,209.30 | |
| May 8, 2023 | Major Shareholder | 57,073 | $1.95 | Buy | $111,292.35 | |
| May 5, 2023 | Major Shareholder | 166,823 | $1.92 | Buy | $320,300.16 | |
| May 3, 2023 | Major Shareholder | 18,513 | $1.85 | Buy | $34,249.05 | |
| Dec. 12, 2022 | CEO | 10,613 | $1.10 | Sell | $11,674.30 | |
| Dec. 12, 2022 | Insider | 4,586 | $1.10 | Sell | $5,044.60 | |
| Dec. 9, 2022 | Insider | 4,461 | $1.13 | Sell | $5,040.93 | |
| Dec. 9, 2022 | CEO | 10,325 | $1.13 | Sell | $11,667.25 | |
| Dec. 7, 2022 | Insider | 3,928 | $1.28 | Sell | $5,027.84 | |
| Dec. 7, 2022 | CEO | 9,111 | $1.28 | Sell | $11,662.08 | |
| Dec. 5, 2022 | CEO | 8,530 | $1.37 | Sell | $11,686.10 | |
| Dec. 5, 2022 | Insider | 3,686 | $1.37 | Sell | $5,049.82 | |
| Dec. 2, 2022 | Insider | 3,636 | $1.39 | Sell | $5,054.04 | |
| Dec. 2, 2022 | CEO | 8,408 | $1.39 | Sell | $11,687.12 | |
| Nov. 17, 2020 | CFO | 3,666 | $30.00 | Sell | $109,980.00 | |
| Oct. 29, 2020 | Insider | 20,000 | $19.10 | Sell | $382,000.00 | |
| March 20, 2020 | Director | 648 | $7.94 | Sell | $5,145.12 | |
| March 18, 2020 | Director | 3,120 | $6.83 | Sell | $21,309.60 | |
| March 16, 2020 | Director | 17,723 | $6.60 | Sell | $116,971.80 | |
| March 13, 2020 | Director | 52,000 | $6.52 | Sell | $339,040.00 | |
| Dec. 18, 2019 | Major Shareholder | 2,891 | $17.01 | Sell | $49,175.91 | |
| Dec. 11, 2019 | Major Shareholder | 7,743 | $17.65 | Sell | $136,663.95 | |
| Dec. 9, 2019 | Major Shareholder | 139,989 | $17.65 | Sell | $2,470,805.85 | |
| Oct. 22, 2019 | Major Shareholder | 3,888 | $13.42 | Sell | $52,176.96 | |
| Sept. 23, 2019 | Major Shareholder | 416,321 | $17.92 | Sell | $7,460,472.32 | |
| Sept. 4, 2019 | Major Shareholder | 64,104 | $17.11 | Sell | $1,096,819.44 | |
| Feb. 19, 2019 | Director | 666,667 | $15.00 | Buy | $10,000,005.00 | |
| Feb. 19, 2019 | Major Shareholder | 200,000 | $15.00 | Buy | $3,000,000.00 |
Insiders are both buying and selling Tcr2 Therapeutics Inc stock.
The insider traders at Tcr2 Therapeutics Inc are: Morana Jovan-Embiricos, Kevin C Tang, Alfonso Quintas Cardama, Garry E Menzel, Neil W Gibson, Mayur Ian Somaiya, Mpm Asset Management Llc, Robert Hofmeister, and Upnorth Investment Ltd
The most active insider trader at Tcr2 Therapeutics Inc is Morana Jovan-Embiricos with 7 trades.
Morana Jovan-Embiricos has sold the most Tcr2 Therapeutics Inc stock with a total value of $11,315,290.34.
Morana Jovan-Embiricos has bought the most Tcr2 Therapeutics Inc stock with a total value of $20,000,010.00.
The most recent insider trade for Tcr2 Therapeutics Inc was on May 25, 2023.
The single biggest insider buy for Tcr2 Therapeutics Inc was from Morana Jovan-Embiricos with a total value of $10,000,005.00 on Feb. 19, 2019.
The single biggest insider sell for Tcr2 Therapeutics Inc was from Morana Jovan-Embiricos with a total value of $7,460,472.32 on Sept. 23, 2019.